The Skin Temperature Probe market outlook through 2030 is moderately attractive, driven by the secular rise in minimally invasive surgeries and the shift toward single-use sensors that command 18–20 % price premiums. Competitive intensity is escalating as tier-one med-tech firms leverage global procurement contracts, while Asian challengers erode ASPs at 3–4 % CAGR; margin defense now hinges on validated accuracy claims (< ±0.1 °C) and rapid regulatory clearances. Long-term demand will outpace supply by 6–8 % annually, yet capacity additions in Vietnam and Mexico should restore balance by 2027. The innovation frontier centers on stretchable printed thermistors, AI-enabled drift correction, and Bluetooth Low Energy probes that extend continuous monitoring to ambulatory settings. Key risks include sensor element shortages (thermistors, chip-on-flex), price-based tendering in the EU, and cyber-security scrutiny for wireless variants. Strategics should prioritize vertical integration of sensor fabrication, pursue tuck-in deals for algorithmic IP, and secure dual sourcing of noble-metal inks to safeguard EBIT above 22 %.